We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Human Babesiosis in Europe: what clinicians need to know.
- Authors
Hildebrandt, A.; Gray, J. S.; Hunfeld, K.-P.
- Abstract
Although best known as an animal disease, human babesiosis is attracting increasing attention as a worldwide emerging zoonosis. Humans are commonly infected by the bite of ixodid ticks. Rare ways of transmission are transplacental, perinatal and transfusion-associated. Infection of the human host can cause a very severe host-mediated pathology including fever, and hemolysis leading to anemia, hyperbilirubinuria, hemoglobinuria and possible organ failure. In recent years, apparently owing to increased medical awareness and better diagnostic methods, the number of reported cases in humans is rising steadily worldwide. Hitherto unknown zoonotic Babesia spp. are now being reported from geographic areas where babesiosis was not previously known to occur and the growing numbers of travelers and immunocompromised individuals suggest that the frequency of cases in Europe will also continue to rise. Our review is intended to provide clinicians with practical information on the clinical management of this rare, but potentially life-threatening zoonotic disease. It covers epidemiology, phylogeny, diagnostics and treatment of human babesiosis and the potential risk of transfusion-transmitted disease with a special focus on the European situation.
- Subjects
EUROPE; BABESIOSIS diagnosis; TREATMENT of babesiosis; BABESIOSIS; META-analysis; PATIENT monitoring; POLYMERASE chain reaction; PREVENTIVE health services; TICK-borne diseases; ZOONOSES; SYSTEMATIC reviews
- Publication
Infection, 2013, Vol 41, Issue 6, p1057
- ISSN
0300-8126
- Publication type
Article
- DOI
10.1007/s15010-013-0526-8